switching between glp 1 agonists chart Outcomes in GLP-1 RA-Experienced Patients to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study | Diabetes Therapy Science Behind GLP 1 GIP
Description
The system is not stabilizing
However, many of these drugs were associated with unexpected adverse effects, such as nausea, aversion, valvular heart disease, and even suicidal tendencies, leading to the discontinuation of most of their development
doi: 10.1001/jama.281.21.2005
The effects of GLP1(736) on cells may also be indirect, mediated through insulin and glucagon released by and cells, respectively, which can alter somatostatin secretion
doi: 10.1111/dom.12084 23 ArslanianSAHannonTZeitlerPChaoLCBoucher-BerryCBarrientos-PrezMet al
Diabetes Care 2018;41:26692701 [DOI] [PMC free article] [PubMed] [Google Scholar] 5.Buse JB, Wexler DJ, Tsapas A, et al
